ACTIVE

Enzo Life Sciences

Export PDF

Financial year 2025 · closed on 31/07/2025

Net result

-185,8 k €

-36.4% YoY

Revenue

814,9 k €

-62.6% YoY

Equity

-1 M €

-22.0% YoY

Workforce

1,0 ETP

0.0% YoY

What does Enzo Life Sciences do?

Enzo Life Sciences is a Private limited company incorporated in 1996. Its registered office is in Ixelles. It employs on average 1,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0459.284.211

Incorporation

25/11/1996

Legal form

Private limited company

Registered office

Avenue Louise 65 box 11
1050 Ixelles · BruxellesSee on map

Contributed capital

18 592,01 €

Latest accounts

31/07/2025

Average workforce

1,0 ETP

Joint committees (1)

Signals

Good liquidityHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2015		2014		2013		2011		2010		2009		2008		2007
Income statement
Revenue	814,9 k €	-62.6%	2,2 M €	+63.9%	1,3 M €	+22.8%	1,1 M €	+3.6%	1 M €	+34.4%	778,1 k €	-19.2%	962,5 k €	+38.2%	696,3 k €	-13.5%	805,3 k €	+10.2%	730,6 k €	+15.8%	630,7 k €	-17.0%	759,7 k €	-27.3%	1 M €	+12.4%	930,6 k €	+6.3%	875,3 k €	+79.1%	488,6 k €		–
EBITDA	-181,7 k €	-44.2%	-126 k €	+12.8%	-144,5 k €	-107%	-69,8 k €	+6.8%	-75 k €	+40.9%	-126,9 k €	-109%	-60,7 k €	+40.5%	-102 k €	-48.3%	-68,8 k €	-315%	31,9 k €	-2.5%	32,8 k €	-53.7%	70,8 k €	-34.5%	108,1 k €	+722%	13,1 k €	-71.8%	46,6 k €	+226%	14,3 k €	+253%	-9,3 k €
Operating result	-182,5 k €	-37.2%	-133,1 k €	+5.2%	-140,3 k €	-88.6%	-74,4 k €	+3.1%	-76,8 k €	+39.3%	-126,5 k €	-121%	-57,3 k €	+44.8%	-103,8 k €	-46.6%	-70,8 k €	-322%	31,9 k €	-49.1%	62,7 k €	-11.4%	70,8 k €	-31.2%	102,9 k €	+1718%	5,7 k €	-85.3%	38,6 k €	+288%	9,9 k €	+172%	-13,8 k €
Net result	-185,8 k €	-36.4%	-136,2 k €	+5.2%	-143,7 k €	-84.3%	-78 k €	+2.3%	-79,8 k €	+38.0%	-128,7 k €	-118%	-59 k €	+44.1%	-105,6 k €	-45.8%	-72,5 k €	-338%	30,5 k €	-46.2%	56,6 k €	-32.2%	83,6 k €	+8.7%	76,9 k €	+4070%	-1,9 k €	-106%	33,5 k €	+303%	8,3 k €	+107%	-121,5 k €
Balance sheet
Equity	-1 M €	-22.0%	-845,4 k €	-19.2%	-709,1 k €	-25.4%	-565,5 k €	-16.0%	-487,5 k €	-19.6%	-407,7 k €	-46.2%	-278,9 k €	-26.8%	-219,9 k €	-92.4%	-114,3 k €	-605%	22,7 k €	+390%	-7,8 k €	+87.9%	-64,5 k €	-237%	47 k €	+258%	-29,8 k €	-6.9%	-27,9 k €	+54.6%	-61,4 k €	+11.9%	-69,7 k €
Total assets	142,7 k €	-71.7%	503,5 k €	+85.8%	271 k €	-2.3%	277,3 k €	+69.0%	164,1 k €	+21.5%	135 k €	-52.1%	282 k €	+179%	101 k €	-45.7%	185,9 k €	+35.4%	137,3 k €	-41.4%	234,3 k €	+71.7%	136,4 k €	-58.6%	329,8 k €	+32.9%	248,2 k €	+35.2%	183,6 k €	-13.6%	212,4 k €	+43.7%	147,9 k €
Cash	30,1 k €	-39.2%	49,4 k €	+63.6%	30,2 k €	+38.9%	21,8 k €	-12.6%	24,9 k €	-16.5%	29,8 k €	-58.6%	72 k €	+210%	23,2 k €	-63.7%	63,9 k €	+29.2%	49,4 k €	-60.7%	125,6 k €	+456%	22,6 k €	-76.6%	96,4 k €	-10.1%	107,2 k €	+105%	52,2 k €	-14.7%	61,2 k €	+44.1%	42,5 k €
Debts	1,2 M €	-13.0%	1,3 M €	+37.6%	980,1 k €	+16.3%	842,7 k €	+29.3%	651,6 k €	+20.1%	542,7 k €	-3.2%	560,9 k €	+74.8%	320,9 k €	+6.9%	300,1 k €	+165%	113,4 k €	-53.0%	241,6 k €	+24.4%	194,2 k €	-28.6%	271,8 k €	+1.7%	267,3 k €	+43.2%	186,7 k €	-29.5%	264,7 k €	+21.6%	217,6 k €
Other
Workforce	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	-44.4%	1,8 ETP	-30.8%	2,6 ETP	+30.0%	2,0 ETP	+17.6%	1,7 ETP	+41.7%	1,2 ETP

Governance

Board of directors

Seen on filing of 31/07/2025 · 2 active · 18 ended

Active mandates

Jason Apter

Director · since 15 septembre 2025

Active

Kara Anne Cannon

Director · since 06 septembre 2023 · until 15 septembre 2025

Active

Ended mandates

Kara Anne Cannon

Director · since 06 septembre 2023

Ended

David Bench

Director · since 30 mars 2022 · until 14 novembre 2022

Ended

Hamid Reza Erfanian

Director · since 30 mars 2022 · until 06 septembre 2023

Ended

Hamid Reza Erfanian

Director · since 30 mars 2022

Ended

At this address

Other companies at this address

Company	CBE no.
225 Mezz HoldCo● Active	0746.605.436
225 Senior HoldCo● Active	0746.605.535
AAHR SRL● Active	0794.230.555
Aalst Groeneweg Business Centre● Active	0635.489.461
ABL GROUP● Active	0751.628.551
ACCURACY FINANCE● Active	0642.608.568
AFRIREGISTER.EU● Active	0651.981.540
AGAD Technology● Active	0788.823.103
AGROKTIMA● Active	0452.099.875
AISMA PMP SERVICES● Active	0797.614.667
ALARM MASTERS SA/NV● Active	0502.903.230
Alliance for AI, IoT and Edge Continuum Innovation● Active	0663.895.516
ALPHA LOGICA● Active	0456.386.384
Alta Signa Europe● Active	0737.925.817
AMERICAN ENERGY MARKETING● Bankrupt	0430.558.650
ANSUL● Active	0441.557.163
ANSUL BELGIUM● Active	0860.511.744
ANTWERP BUSINESS CENTER● Active	0438.584.906
Antwerp Campus West Blancefloerlaan Centre● Active	0720.755.530
Antwerp City Centre● Active	0597.671.834

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/08/2024	01/08/2023	01/08/2022	01/08/2021	01/08/2020	01/08/2019
Closing of the financial year	31/07/2025	31/07/2024	31/07/2023	31/07/2022	31/07/2021	31/07/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/01/2026	13/01/2025	23/01/2024	23/02/2023	10/01/2022	15/01/2021
General meeting	12/01/2026	13/01/2025	08/01/2024	09/01/2023	10/01/2022	11/01/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/07/2025	12/01/2026	14/01/2026	Dutch	PDF
Full model	31/07/2024	13/01/2025	13/01/2025	Dutch	PDF
Full model	31/07/2023	08/01/2024	23/01/2024	Dutch	PDF
Full model	31/07/2022	09/01/2023	23/02/2023	Dutch	PDF
Full model	31/07/2021	10/01/2022	10/01/2022	Dutch	PDF
Full model	31/07/2020	11/01/2021	15/01/2021	Dutch	PDF
Full model	31/07/2019	13/01/2020	07/02/2020	Dutch	PDF
Full model	31/07/2018	14/01/2019	31/01/2019	Dutch	PDF
Full model	31/07/2017	08/01/2018	20/02/2018	Dutch	PDF
Full model	31/07/2016	28/02/2017	15/03/2017	Dutch	PDF
Full model	31/07/2015	11/01/2016	28/01/2016	Dutch	PDF
Full model	31/07/2014	13/01/2015	29/01/2015	Dutch	PDF
Full model	31/07/2013	13/01/2014	25/02/2014	Dutch	PDF
Full model	31/07/2011	31/01/2012	02/03/2012	Dutch	PDF
Full model	31/07/2010	10/01/2011	28/02/2011	Dutch	PDF
Full model	31/07/2009	11/01/2010	19/03/2010	Dutch	PDF
Full model	31/07/2008	12/01/2009	04/03/2009	Dutch	PDF
Abridged model	31/12/2007	05/05/2008	26/08/2008	Dutch	PDF
Abridged model	31/12/2006	07/05/2007	30/07/2007	Dutch	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/07/2025 · 2 active · 18 ended

Active mandates

Jason Apter

Director · since 15 septembre 2025

Active

Kara Anne Cannon

Director · since 06 septembre 2023 · until 15 septembre 2025

Active

Ended mandates

Kara Anne Cannon

Director · since 06 septembre 2023

Ended

David Bench

Director · since 30 mars 2022 · until 14 novembre 2022

Ended

Hamid Reza Erfanian

Director · since 30 mars 2022 · until 06 septembre 2023

Ended

Hamid Reza Erfanian

Director · since 30 mars 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates10/11/2025
HERBENOEMING COMMISSARIS - ONTSLAG EN BENOEMING
PDF
Mandates20/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/03/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/12/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/11/2020
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Mandates09/04/2019
ONTSLAGEN - BENOEMINGEN
PDF
Registered office23/11/2017
MAATSCHAPPELIJKE ZETEL
PDF
Mandates08/06/2017
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-185,8 k €↓
2024
Annual accounts 2024-136,2 k €↑
2023
Annual accounts 2023-143,7 k €↓
2022
Annual accounts 2022-78 k €↑
2021
Annual accounts 2021-79,8 k €↑
2020
Annual accounts 2020-128,7 k €↓
2019
Annual accounts 2019-59 k €↑
2018
Annual accounts 2018-105,6 k €↓
2017
Annual accounts 2017-72,5 k €↓
2015
Annual accounts 201530,5 k €↓
2014
Annual accounts 201456,6 k €↓
2013
Annual accounts 201383,6 k €↑
2011
Annual accounts 201176,9 k €↑
2010
Annual accounts 2010-1,9 k €↓
2009
Annual accounts 200933,5 k €↑
2008
Annual accounts 20088,3 k €↑
2007
Annual accounts 2007-121,5 k €
25/11/1996
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Enzo Life Sciences

Overview

What does Enzo Life Sciences do?

Trend over 17 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline